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Abstract:
Objective: This study investigates whether anxiety modulates cognitive-
performance, electrophysiological and electrodermal processes that we 
previously found impaired in individuals with ADHD. 
Method: Self-reported anxiety symptoms, cognitive-electrophysiological 
measures of response inhibition, working memory, attention, conflict-
monitoring, error-processing, and peripheral arousal during three 
cognitive tasks were obtained from 87 adolescents and young adults with 
ADHD and 169 controls. We tested the association of anxiety symptoms 
with each measure and whether controlling for anxiety symptoms 
attenuates the ADHD-control difference for each measure. 
Results: Individuals with ADHD showed significantly elevated anxiety 
symptoms compared to controls. Only commission errors on a 
Continuous Performance Test (measuring response inhibition) were 
significantly associated with anxiety symptoms and only among controls, 
with the ADHD-control difference in this measure remaining significant. 
Conclusion: Using a wide range of cognitive, electrophysiological and 
electrodermal measures, our investigation suggests, overall, limited 
malleability of these impairments in individuals with ADHD irrespective of 
their levels of anxiety.
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INTRODUCTION
Anxiety is one of the most frequent psychiatric comorbidities in children and adolescents with 
attention-deficit/hyperactivity disorder (ADHD) (Elia, Ambrosini, & Berrettini, 2008; Larson, Russ, 
Kahn, & Halfon, 2011). Individuals with ADHD who have a co-occurring anxiety disorder show greater 
functional impairment, as well as social and emotional problems, than those with ADHD alone (Bowen, 
Chavira, Bailey, Stein, & Stein, 2008), and the response to ADHD medications may be attenuated in 
the presence of co-occurring anxiety disorders or symptoms (Jensen et al., 2001; Moshe, Karni, & 
Tirosh, 2012). Poorer long-term outcomes have also been reported, in that youths with comorbid 
ADHD and anxiety have a higher risk of developing emotional and social problems later in life than 
those with ADHD only (Angold, Costello, & Erkanli, 1999; Halmoy, Fasmer, Gillberg, & Haavik, 2009; 
Newcorn et al., 2004; Tannock, 2009). 
To understand the mechanisms underlying the poor functioning and outcomes in individuals with 
ADHD and comorbid anxiety, investigators have examined whether anxiety has an impact on the 
cognitive impairments typically associated with ADHD. Early theoretical models proposed that anxiety 
symptoms of worry have damaging effects on storing and processing capacities of verbal working 
memory, ultimately interfering with attentional control (Eysenck, Derakshan, Santos, & Calvo, 2007; 
Humphreys & Revelle, 1984). This was supported by the results of initial studies on individuals with 
ADHD (Schatz & Rostain, 2006; Tannock, 2009). A second existing hypothesis additionally proposes a 
‘protective’ role of anxiety for inhibitory deficits (Schatz & Rostain, 2006). The interference account of 
anxiety on inhibitory control in ADHD has been tentatively explained with an improved balance 
between Quay’s behavioural inhibition system (BIS) and behavioural activation system (BAS) (Schatz 
& Rostain, 2006). By pooling the results of 11 studies, a recent meta-analysis suggested that, relative 
to individuals with ADHD alone (n=695), those with both ADHD and an anxiety disorder (n=608) had 
better response inhibition, but did not differ on attention or working memory measures (Maric, 
Bexkens, & Bogels, 2018). While supporting the potential attenuation effects of anxiety on inhibitory 
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deficits in individuals with ADHD, this more recent evidence does not corroborate the negative 
interference of anxiety on attention and working memory functions in ADHD. Yet, it was noted that 
wide age ranges and predominantly male samples may limit the effects on attention and working 
memory, respectively (Maric et al., 2018). 
A few other studies have investigated the effects of comorbid anxiety on cognitive processes in 
individuals with ADHD when measuring anxiety as a continuum rather than as a diagnosis. Findings 
have indicated that high anxiety ratings were associated with better inhibition in both youths with 
ADHD and controls (Bloemsma et al., 2013; Ruf, Bessette, Pearlson, & Stevens, 2017). Only one of 
these studies tested the association of anxiety with working memory performance, showing no 
significant effects of anxiety on this measure (Bloemsma et al., 2013). For attention and vigilance 
measures, the findings have been mixed. One study reported that high anxiety traits in individuals 
with ADHD were associated with reduced omission rates, mean response speed and response 
variability in a continuous performance task (Ruf et al., 2017), while another study using a simple 
reaction time (RT) task indicated slower response speed in relation to anxiety traits (Bloemsma et al., 
2013). Of note, in a recent study the attenuation effects of anxiety on measures of attention 
(omissions), response speed and variability were observed in youths with ADHD, but not in controls 
(Ruf et al., 2017), suggesting malleability of these cognitive functions in relation to anxiety only in 
individuals with ADHD. Overall, dimensional and categorical approaches converge in supporting the 
putative protective role of anxiety on inhibitory deficits in ADHD, but findings are mixed on whether 
attention and memory impairments in individuals with ADHD are affected by anxiety. Further, 
previous studies suggest that while co-occurring anxiety symptoms reduced the level of impairments 
observed in individuals with ADHD on a number of cognitive measures, the ADHD-control differences 
remained significant (Ruf et al., 2017). Therefore it remains unclear whether anxiety effects produce 
meaningful attenuations on the observed ADHD-related impairments.    
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Investigations on the moderating effects of anxiety in individuals with ADHD have almost entirely 
focused on cognitive performance. Although atypical profiles have also been documented at the brain 
level in ADHD in several electroencephalography (EEG) studies (Johnstone, Barry, & Clarke, 2013; Tye, 
McLoughlin, Kuntsi, & Asherson, 2011), little is known about the mechanisms of the potential 
protective or interfering roles of anxiety on these impairments. Using event-related potentials (ERPs), 
one small-scale study examined the similarities and differences on neurophysiological impairments 
between participants with ADHD only and those with comorbid ADHD and an anxiety disorder 
(Klymkiw et al., 2017). Youth with both ADHD and an anxiety disorder showed milder impairments in 
response inhibition (commission errors) and ERP activity of conflict-monitoring (N2 following no-go 
stimuli), as well as in early EEG measures reflecting auditory selective attention (early frontal positivity 
during a selective auditory attention task), compared to those with ADHD only (Klymkiw et al., 2017). 
Thus, by measuring the brain dysfunctions in ADHD with and without co-occurring anxiety symptoms, 
the use of EEG measures may shed light on which cognitive and brain processes are linked to the 
modulating effects of anxiety in ADHD.  
Another physiological measure that may help understand the role of anxiety on the ADHD-related 
impairments is skin conductance (SC), a measure of electrodermal activity and an objective index of 
arousal in the peripheral nervous system (Boucsein, 1992). Elevated SC tonic levels and reactivity to 
threat stimuli are well-known associated features of anxiety (Craske et al., 2008; Erath, Tu, & El-Sheikh, 
2012). Our group previously demonstrated that individuals with ADHD show lower tonic levels of 
peripheral arousal measured with SC during a simple 4-choice RT task, relative to controls (James, 
Cheung, et al., 2017). Yet, no study to date has investigated whether anxiety moderates arousal 
impairments in individuals with ADHD.
In the present study, we investigate whether anxiety modulates the cognitive, physiological and brain 
impairments that have been shown to link to ADHD in our previous analyses on adolescents and young 
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adults with ADHD and typically developing controls (Cheung et al., 2017; Cheung et al., 2016; James, 
Cheung, et al., 2017; Michelini et al., 2018; Michelini et al., 2016). In a preliminary step, we aim to 
confirm previous findings that individuals with ADHD have elevated anxiety symptoms relative to 
controls (Elia et al., 2008). We then test whether high anxiety levels associate with a range of cognitive-
performance, EEG and skin conductance measures of response inhibition, working and short-term 
memory, attention, error processing and peripheral arousal, both in individuals with ADHD and, for 
comparison, in controls. While it could be hypothesised that high anxiety traits are related to better 
response-inhibition measures, no formal predictions were made for the attenuation or exacerbation 
effects of anxiety on attention, memory and neurophysiological measures owing to the limited and 
inconsistent existing literature. If a significant interaction effect between anxiety symptoms and group 
emerges, we further examine whether the ADHD-control difference on the measure is significantly 
attenuated when controlling for anxiety symptoms. Finally, given previous findings of attenuated 
cognitive impairments in presence of anxiety in samples with higher proportion of males than females 
(Maric et al., 2018), and given that our sample includes only a small number of females, we repeat the 
analyses when including male participants only. 
METHODS
Sample
ADHD and control groups, who had taken part in previous research (W. Chen et al., 2008; Kuntsi et al., 
2010), were invited to take part in a follow-up study (Cheung et al., 2016; Cheung et al., 2015; 
Michelini et al., 2018). The ADHD group was initially recruited from specialised ADHD clinics in the UK, 
and the control group was recruited from primary and secondary schools in the UK. Exclusion criteria 
for both groups included IQ<70, autism, epilepsy, brain disorders and any genetic or medical disorder 
associated with externalising behaviours that might mimic ADHD. After exclusion of the participants 
with childhood-ADHD that no longer met criteria for ADHD (n=25) and controls meeting ADHD criteria 
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(n=9) at follow-up, the final sample consisted of 87 individuals with an ADHD diagnosis at follow-up 
(14 full pairs, 73 singletons) and 169 control siblings (76 full pairs, 17 singletons) (Table 1). Written 
informed consent was obtained following procedures approved by the London-Surrey Borders 
Research Ethics Committee (09/H0806/58).
Procedure
Participants attended a single 4.5h research session, which included a cognitive-EEG assessment, an 
IQ test and clinical interviews, including the Diagnostic Interview for ADHD in adults (DIVA) (Kooij & 
Francken, 2007) and the Barkley Functional Impairment Scale (BFIS) (Barkley & Murphy, 2006). Parent-
reported ADHD symptoms and impairment obtained from face-to-face clinical interviews were used 
to determine ADHD status in the ADHD group and parent-reported ADHD ratings were used to identify 
controls meeting ADHD diagnostic criteria, as described previously (Cheung et al., 2016; James, 
Cheung, Rijsdijk, Asherson, & Kuntsi, 2016; Michelini et al., 2016). For the participants with ADHD who 
were being treated with stimulant medications (n = 43), a 48-hr ADHD medication-free period was 
required prior to the cognitive-EEG assessments. Information on lifetime use of non-pharmacological 
interventions for ADHD or history of treatment for anxiety disorders was not available.
Measures
Anxiety symptoms
The Clinical Interview Schedule Revised (CIS-R) was used to identify symptoms of anxiety.  The anxiety 
disorders sections of this semi-structured interview were conducted by trained researchers with the 
participants as part of a research diagnostic assessment. Each of the Anxiety, Phobias and Panic 
disorders scales included items relating to the severity and duration of symptoms (Lewis, Pelosi, Araya, 
& Dunn, 1992). The anxiety symptoms scores were formed by combining the sum of yes/no (i.e., 1 or 
0) scores from four subscales: a subscale of ‘worry’, a subscale of ‘anxiety’, a subscale of ‘phobias’ and 
a subscale ‘panic’, each with a maximum score of 4. As a result, the total anxiety symptoms score was 
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comprised of 36 items, with a maximum score of 16. Obsessive-compulsive traits were also examined 
as part of the interview and included in the anxiety symptoms scores in a supplementary analysis; 
obsessive-compulsive traits included the obsessions and compulsions subscales, each giving a 
maximum score of 4.  The CIS-R has good internal validity with a Cronbach’s alpha score of 0.82 
reported (Lewis et al., 1992), and was developed for use by non-clinical interviewers.
IQ and memory estimates
The verbal and performance design subtests of the Wechsler Abbreviated Scale of Intelligence (WASI) 
(Wechsler, 1999) were administered to all participants to derive IQ estimates. The digit span subtest 
from the Wechsler Intelligence Scale for Children (WISC-III) (Wechsler, 1991) or the WAIS-III 
(Wechsler, 1997) was administered to participants aged below 16 and 16 or above, respectively, to 
obtain digit span forward and backward. The forward test measures short-term verbal memory, while 
the backward test is a measure of working memory.
The Cued-Continuous Performance Test (CPT-OX) 
The CPT-OX is a cued Go/NoGo task that probes attention, preparation and response inhibition 
(Doehnert, Brandeis, Imhof, Drechsler, & Steinhausen, 2010). The task consists of 400 black letter 
arrays, formed of a centre letter and incompatible flankers on each side. The task involves the 
pseudorandomized presentation of 80 Cues ("XOX") followed either by 40 Go ("OXO") and 40 NoGo 
("XDX") stimuli, or by random letter arrays as neutral distractors (e.g. “XBX”). Participants were 
instructed to respond only to target letters in Cue-Go sequences, and to withhold the response in 
presence of a NoGo stimulus, or a Go not preceded by a Cue (40 trials), or of any other irrelevant 
letters. Task duration was approximately 11 min.
The Arrow Flanker task
The task was an adaptation of the Eriksen flanker paradigm designed to increase cognitive load as 
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used in previous studies (Albrecht et al., 2008; McLoughlin et al., 2009). In each trial a central black 
fixation mark was replaced by a target arrow (a black 18-mm equilateral triangle). Participants had to 
indicate whether this arrow pointed towards the left of right by pressing corresponding buttons with 
their left or right index fingers. Both flankers either pointed in the same (congruent) or opposite 
(incongruent) direction to the target. As such, conflict monitoring is maximal during the incongruent 
condition. 
The Fast Task  
Participants performed a four-choice RT task with a baseline condition (72 trials) with four empty 
circles (warning signals, arranged horizontally) first appearing for 8000ms, after which one of them 
(the target) was coloured in (Kuntsi, Andreou, Ma, Borger, & van der Meere, 2005). Participants were 
asked to press the response key that directly corresponded to the position of the target. A comparison 
condition with a fast event rate (1000ms) and incentives followed the baseline condition (Kuntsi et al., 
2005). 
EEG recording and ERP analysis
The signals were recorded from a 62-channels DC-coupled recording system (extended 10–20 
montage) and 2 electro-oculogram electrodes (Brain Products, Germany). Standard down-sampling of 
the data to 256 Hz, digital band-pass filtering (0.1–30 Hz, 24 dB/oct), re-referencing to the average 
reference and eye movement correction are described in (Cheung et al., 2017; Cheung et al., 2016; 
Michelini et al., 2016). ERPs were extracted from the CPT-OX (CNV, Go-P3, NoGo-P3), arrow Flanker 
task (N2, Pe, ERN, incongruent condition only) and Fast Task (CNV and P3) following procedures used 
on previous analyses of this sample ((Cheung et al., 2017; Cheung et al., 2016; Michelini et al., 2016); 
see Supplementary Material 1 for further detail). 
Skin conductance (SC)
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SC data were recorded with reusable 8mm diameter silver-silver chloride electrodes on the 
participant’s non-dominant hand using PSYCHLAB SC5 24-bit equipment system (PSYCHLAB, UK). SC 
data were extracted from the Fast Task involving a skin conductance system based on a SC sigmoid-
exponential model (Boucsein, 1992; Figner & Murphy, 2011; Lim et al., 1997; L. M. Williams et al., 
2000), as described previously (James et al., 2016) (see Supplementary Material 1 for further detail). 
The tonic measure of SC levels was disentangled from phasic stimulus-associated SC responses and 
both measures were calculated per participant in each condition.
Statistical analyses 
Comparison on anxiety symptoms between participants with ADHD and control individuals
The association between ADHD and anxiety symptoms was examined using a regression analysis that 
included anxiety symptoms as the dependent variable and a binary ADHD status variable (ADHD and 
control) as a main effect. The anxiety symptoms scores, measured as the number of total anxiety 
symptoms, were modeled as ordinal. To correct for the non-independence of the data of siblings in 
the ADHD and control groups, the correlation structure of the data was accounted for by calculating 
robust standard errors using the cluster command in Stata 14 (StataCorp) (R. L. Williams, 2000). The 
age range was wide in our sample, thus age was included as a covariate in the analysis. Effect sizes 
(Cohen’s d), which were calculated using the difference in the means divided by the pooled standard 
deviation, are reported. 
Variable selection
The starting point for selecting variables for analysis was to focus on cognitive and neurophysiological 
measures which previously showed ADHD-control differences in this sample (Cheung et al., 2017; 
Cheung et al., 2016; James, Rommel, et al., 2017; Michelini et al., 2016). To reduce the number of 
statistical comparisons, in this analysis we only include those variables where the previously reported 
ADHD-control differences were of moderate-to-large effect size (Cohen’s d  0.50) (Cohen, 1988). 
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According to these criteria, the following cognitive, EEG and SC variables could be retained for 
inclusion in the regression models: digit span forward (DSF) and backward (DSB); mean reaction time 
(MRT), reaction time variability (RTV), the tonic measure of SC level (SCL), and P3 from the baseline 
condition of the Fast Task; omission errors (OE), commission errors (CE), MRT, RTV, CNV and NoGo-P3 
from the CPT-OX; RTV in the congruent and incongruent condition, number of errors in congruent 
trials (CongE) and in incongruent trials (IncongE), and ERN from the Arrow Flanker task. Since all 
measures of MRT and RTV across tasks showed large correlations with one another (r = 0.45-0.76), 
only RTV and MRT from the baseline condition of the Fast Task was included, as these variables 
showed the strongest associations with ADHD (MRT-baseline d = 0.77; RTV-baseline d = 1.23). 
Similarly, as DSB and DSF showed a correlation of r = 0.51, only DSB was included as this measure 
showed the highest effect size in ADHD-control differences (d = 0.70). 
Modelling effects of anxiety
To test the modulating effects of anxiety symptoms on the cognitive, ERP and SC measures, we 
evaluated the relationship between anxiety symptoms and each measure in the ADHD and control 
groups, using a series of regression model analyses. Specifically, we modelled each measure as a 
function of the participant’s anxiety symptoms score, diagnostic group, and their interaction (while 
controlling for the clustering due to sibling relatedness). When a significant interaction between 
anxiety and group emerged for a measure (i.e., indicating a potentially modulating effect of anxiety 
on case-control differences), we compared this model with a simpler model testing only the group 
effect (thus not taking anxiety into account) with likelihood-ratio Chi-square tests. A better fit of the 
former model would indicate that group differences in the measure may be attenuated with increasing 
levels of anxiety. To correct for multiple testing, we estimated the equivalent number of effective 
variables using the correlation matrix of the examined measures 
(http://gump.qimr.edu.au/general/daleN/matSpD/), and performed Bonferroni correction on the 
total effective tests. The effective number of independent variables was 10.4 and the resulting 
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multiple-testing adjusted p-value was 0.0048. Any post-hoc analyses of effects surviving multiple-
testing correction used the nominal significance level (0.05). 
All cognitive-ERP measures and SCL were log-transformed to normal and standardized prior to 
analysis, except OE, CE and CongE that were highly skewed and could not be normalized using any 
transformation method; they were therefore modeled as ordinal. Anxiety scores were also 
standardized so that beta coefficients represent a standardized effect size measure. Specifically, a 1-
standard deviation change in the anxiety symptoms score leads to  change in standard deviation in 
the examined measures in the overall sample, as well as in the ADHD affected status compared to the 
unaffected status. 
As obsessive-compulsive disorder was classified as an anxiety disorder in previous classification 
systems (American Psychiatric Association, 2000), regression model analyses were repeated by 
replacing the anxiety symptom scores with a combined anxiety and obsessive-compulsive trait score. 
Since IQ was significantly decreased in the ADHD group is this sample (Cheung et al. 2016, Michelini 
et al. 2018), we re-ran all analyses covarying for IQ to examine its potential effects on the observed 
associations. Groups were matched on sex (Table 1) and primary analyses were performed on the 
whole sample without accounting for sex differences. As the majority of our sample consisted of male 
participants (80%), a secondary analysis was performed with the female participants (15 ADHD 
probands and 40 control participants) removed. 
RESULTS
Anxiety symptoms in participants with ADHD vs. controls
Individuals with ADHD (mean = 1.6; SD = 2.4; range=0–12) showed significantly higher anxiety 
symptoms relative to controls (mean = 0.9; SD = 1.6; range = 0–8; F(2,172) = 5.53; p < 0.05; d = 0.36; 
Figure 1; Supplementary Figure 1). 
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Do anxiety symptoms associate with the cognitive, ERP and skin conductance measures? 
The main effect of anxiety symptoms was not significant for any of the examined cognitive, ERP, or 
electrodermal activity measures (Table 2). For CE on the CPT-OX, but not for any other variable, a 
significant interaction emerged between anxiety symptoms and group (Table 2). Post-hoc examination 
of the separate effects of anxiety for each group revealed that higher anxiety symptoms were 
associated with fewer CE (i.e., with better cognitive performance) in controls  = -0.37; 95% CI = -
0.65,-0.10; p < 0.01), but were not significantly associated with CE in individuals with ADHD (with a 
positive non-significant coefficient value of  = 0.25; 95% CI = -0.05,0.57; p = 0.10). Together with the 
negative coefficient for the anxiety x group interaction effect, these results indicate that with 
increasing anxiety, CE decreased in the control group but not in the ADHD group (Figure 2). Controlling 
for IQ, the group x anxiety interaction effect for CE on the CPT-OX remained significant, with a negative 
association of anxiety with CE in the controls but not in individuals with ADHD (Supplementary Table 
S1). When analyses were repeated including obsessive-compulsive traits to the anxiety scores, no 
significant effects of anxiety emerged for the examined measures, and the interaction between 
combined anxiety symptoms scores and group for CE on the CPT-OX reduced in magnitude and 
became non-significant (Supplementary Table S2).
Do anxiety symptoms modulate the case-control differences on the cognitive, ERP and skin 
conductance measures? 
Follow-up examination of the group effects in the regression model testing the effects of anxiety on 
CE revealed that, taking into account the effect of anxiety, the group effect on CE was significant  = 
0.41; 95% CI = 0.02,0.81; p = 0.04). This effect size was reduced compared to that observed in a model 
repeated without taking into account anxiety effects  = 0.71; 95% CI = 0.36,1.05; p < 0.001; as also 
reported in Cheung et al., 2016; Michelini et al., 2016). The Chi-square test indicated that the group 
differences alone accounted for 4.3% of the variation in CE 2(2,255) = 16.07, p < 0.001); adding the 
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effects of anxiety significantly improved the prediction of CE beyond ADHD-control differences (R2 = 
0.063, 2(4,255) = 24.74, p < 0.001; difference in R2 = 0.02, 2(4,255) = 9.99, p = 0.007). As a significant 
interaction only emerged between anxiety symptoms and CE, Chi-square tests were not performed 
on any of the remaining measures.  
Do anxiety symptoms associate with the cognitive, ERP and skin conductance measures in a male-only 
subsample? 
When repeating the analysis with female participants removed, the difference between participants 
with ADHD and controls on anxiety symptoms remained significant (d = 0.43; F(1,159) = 7.33, p < 0.01). 
Similarly, results for CE on the CPT-OX remained substantially unchanged in the male-only sample 
(Table 3): while the interaction between anxiety symptoms and group on CE did not survive multiple-
testing correction, the effect size of this interaction effect in the male-only sample (  = 0.59; Table 3) 
was similar compared with that of the full sample (  = 0.57; Table 2). In the male-only sample, 
additional main effects of anxiety on MRT and RTV on the Fast Task did not survive correction for 
multiple testing and results remained unchanged for other cognitive-performance measures, the SCL 
in the Fast Task and all ERP measures (Table 3). 
DISCUSSION
We performed a detailed investigation of the modulation effects of anxiety on electrophysiological 
and electrodermal activity measures, as well as on cognitive performance, in a well-characterised 
sample of adolescents and young adults with ADHD, and age- and gender-matched controls. We first 
confirmed previous evidence of increased anxiety symptoms in individuals with ADHD (Elia et al., 
2008). Second, analyses revealed that higher anxiety symptoms were associated with better response 
inhibition in controls, but not in individuals with ADHD, suggesting that individuals with ADHD may 
not benefit from the hypothesised protective effects of anxiety on inhibitory impairments (Schatz & 
Rostain, 2006; Tannock, 2009). No effects of anxiety were observed on the remaining cognitive, 
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electrophysiological and electrodermal activity measures in the full sample, or on any measure when 
limiting analyses to a male-only sample. 
Using a self-report measure of anxiety symptoms obtained from a validated clinical interview, we 
found that adolescents and young adults with ADHD in our sample presented with modest to 
moderate increases in anxiety symptoms relative to neurotypical individuals. This is in line with a large 
body of evidence showing high rates of comorbid anxiety disorders in individuals with ADHD across 
the lifespan (Elia et al., 2008; Larson et al., 2011; Solberg et al., 2018). Family and molecular genetic 
studies also indicate that anxiety disorders are associated with ADHD at the genetic level (Anttila et 
al., 2017; T. J. Chen et al., 2016; Du Rietz et al., 2018; Michelini, Eley, Gregory, & McAdams, 2015; 
Schmitz & Mrazek, 2001; Spatola et al., 2007). For the clinician, these findings confirm the importance 
of implementing early screening of psychiatric symptoms such as anxiety in individuals with ADHD, to 
ensure efficient intervention strategies as recommended in current UK clinical guidelines 
(https://www.nice.org.uk/guidance/qs53).
Our findings indicate an enhancing role of anxiety on response inhibition in controls and not in 
individuals with ADHD, as indicated by the significant interaction between anxiety symptoms and 
ADHD diagnosis on commission errors in the CPT-OX in the full sample. Additionally, we found no 
significant mitigation effects of anxiety on the remaining cognitive, electrophysiological and 
electrodermal activity measures, and the mitigation effects of anxiety on inhibition impairments were 
weaker when obsessive-compulsive traits were included in the anxiety scores. Our results are in line 
with a recent meta-analysis showing that, when pooling 11 studies which compared youth with ADHD 
and those with comorbid ADHD-anxiety, there were no differences in attention and working memory 
impairments in individuals with both ADHD and an anxiety disorder compared to those with ADHD 
only (Maric et al., 2018). However, our results did not align with previous evidence showing that high 
anxiety symptoms or anxiety disorders may ameliorate inhibition impairments in individuals with 
Effects of anxiety on ADHD-related impairments
15
ADHD (Bloemsma et al., 2013; Maric et al., 2018; Ruf et al., 2017). It is worth noting that the 
association between anxiety disorders and reduced impairments in cognitive inhibition was limited to 
studies with medication-naive participants in the meta-analysis by Maric and colleagues (2018). The 
authors suggested that individuals who require pharmacological treatment may show more severe 
impairments in cognitive functioning (Maric et al., 2018) that are not modifiable with increasing levels 
of anxiety. Our ADHD sample included all individuals with a combined ADHD presentation at baseline, 
thus possibly most severe, and with persistent ADHD symptoms and impairments since childhood or 
adolescence (Cheung et al., 2015), therefore indicating that ADHD-related impairments may not be 
malleable to the mitigating effects of anxiety at such severe and persistent levels of ADHD symptoms 
and impairments.
For response inhibition, ADHD-control differences were significantly reduced (from a medium to a 
small effect size) when controlling for anxiety symptoms. Anxiety symptoms have been hypothesised 
to enhance effort and increase use of processing resources (Eysenck et al., 2007). Our findings indicate 
that this hypothesis may hold for controls, but not for individuals with ADHD. 
When limiting analyses to male participants, no significant additional effects of anxiety emerged. 
Unlike the meta-analysis by Maric and colleagues (Maric et al., 2018), we did not find that the presence 
of anxiety links with attenuated working memory deficits in male participants with ADHD. The lack of 
beneficial effects of anxiety traits on working memory impairments in our sample may results from 
the use of the digit span of the Wechsler scale, which yielded heterogeneous results in the previous 
studies summarised in the recent meta-analysis (Maric et al., 2018). Further studies, using more 
detailed measures of working memory, i.e., from computerised tasks such as the Cambridge 
Neuropsychological Test Automated Battery (CANTAB; Morris, Evendon, Sahakian, & Robbins, 1987), 
will need to clarify this issue further. Suggestive, yet non-significant, associations of anxiety symptoms 
with faster and less variable RTs in both ADHD and control male-only groups in the present study also 
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encourage further investigations of potential sex differences in how anxiety affects cognitive-
performance measures.
Certain limitations must be taken into consideration. First, as the group of participants with diagnosed 
ADHD in our study included a small sample of females (n = 15), we could not directly investigate 
whether there are differences in the effects of anxiety on the cognitive-neurophysiological measures 
between male and female individuals with ADHD, but were limited to an examination of a male-only 
sub-sample. Moreover, the age range was wide in our sample. This prevented us from examining 
whether the impact of anxiety on cognitive-neurophysiological impairments in ADHD may vary with 
age, similar to a previous report (Maric et al., 2018), as stratifying the analyses by age would have 
resulted in small samples and low power to detect interaction effects. However, as we controlled for 
age in all analyses, it is unlikely that our results are confounded by age effects. Future studies using 
more restricted age ranges and female-only samples should examine these issues further. 
Furthermore, there is emerging evidence pointing to an association of state anxiety – a transitory 
emotional response characterized by feelings of apprehension, nervousness and tension (Spielberger 
et al., 1979) – and ADHD during test performance in young adulthood (Dan & Raz, 2015). While the 
study of state anxiety was not the scope of this study, further studies examining the possible 
association of state anxiety and neuro-cognitive impairments in ADHD are warranted.
In conclusion, despite the observed co-occurrence of ADHD and anxiety symptoms, we obtained no 
evidence consistent with the proposed role of anxiety in modulating cognitive, brain and arousal 
processes in individuals with ADHD (Bloemsma et al., 2013; Maric et al., 2018; Ruf et al., 2017; Schatz 
& Rostain, 2006). An ameliorating effect of anxiety symptoms on response inhibition was observed 
only in controls. Our investigation using a wide range of cognitive and neurophysiological measures 
thus suggests an overall poor malleability of these impairments in individuals with ADHD irrespective 
of their levels of anxiety.                          
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TABLES
Table 1. Sample characteristics
 
ADHD probands 
(n = 87)
Controls 
(n = 169)  
Group 
Comparisons
  (2) p
Males, n (%) 72 (83%) 129 (76%) 1.41 0.23
  mean (SD)  range  mean (SD)  range F(2,172) p
Age, years 18.4 (3.0) 12.1  25.9 17.7 (2.2) 11.9  21.6 1.73 0.09
IQ 97.9 (14.2) 73  129 110.0 (12.4) 73  134  37.37 <0.001
Group differences on sex were tested via chi-square test; group differences on other measures were 
tested with regression models. Group differences between ADHD and control participants were 
reported in previous analyses on this sample (Cheung et al., 2016, 2017; Michelini et al., 2016). SD: 
standard deviation.
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Table 2. Results of regression model analyses showing the main effect of anxiety symptoms and 
the interaction between anxiety symptoms and group on the cognitive-neurophysiological 
measures
  Anxiety symptoms  Group x Anxiety symptoms
 (95% CI) p  (95% CI) p
Memory
DSB  -0.09 [-0.20;0.02] 0.10  0.04 [-0.18;0.26] 0.70
Fast Task
MRT-baseline  0.00 [-0.12;0.12] 0.96  0.16 [-0.08;0.40] 0.19
RTV-baseline  -0.05 [-0.19;0.09] 0.46  0.19 [-0.07;0.46] 0.15
SCL-baseline  -0.08 [-0.20;0.04] 0.18  0.01 [-0.23;0.25] 0.92
CPT-OX
OE  0.05 [-0.18;0.28] 0.70  0.04 [-0.32;0.41] 0.81
CE  -0.16 [-0.39;0.06] 0.16  0.57 [0.21;0.92] 0.002
CNV  -0.01 [-0.10;0.09] 0.88  0.02 [-0.18;0.21] 0.86
NoGo-P3  <0.01 [-0.12;0.11] 0.96  0.14 [-0.09;0.37] 0.23
Arrow Flanker Task
CongE  0.47 [-0.41;1.35] 0.30  0.15 [-0.15;0.44] 0.34
IncongE  0.06 [-0.05;0.16] 0.27  0.17 [-0.06;0.40] 0.14
ERN  -0.04 [-0.18;0.09] 0.54  -0.19 [-0.45;0.06] 0.14
Results from the final regression model examining associations of anxiety symptoms with the cognitive-
neurophysiological measures, as well as the group and the anxiety x group interaction effects, controlling for 
age. ADHD, attention-deficit/hyperactivity disorder; CI: confidence intervals; CongE, errors in the congruent 
condition of the arrow Flanker task; CNV, contingent negative variation from the cued-continuous performance 
test measured at Cz; CPT-OX, cued-continuous performance test; DSB, digit span backward; ERN, error-related 
negativity amplitude from the arrow Flanker task measured at FCz; IncongE, errors in the incongruent condition 
of the arrow Flanker task; MRT-baseline, mean reaction time from the baseline condition of the Fast Task; NoGo-
P3, P3 amplitude in the NoGo condition from the cued-continuous performance test measured at Cz; OE, 
omission errors from the cued-continuous performance test; CE, commission errors from the cued-continuous 
performance test; RTV-baseline, reaction time variability from the baseline condition of the Fast task; SCL-
baseline, skin conductance level in the baseline condition of the Fast Task. Boldface indicates P value remains 
significant following multiple testing (effective number-adjusted P value threshold of 0.0048).
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Table 3. Results of regression model analyses showing the main effect of anxiety symptoms and 
the interaction between anxiety symptoms and group on the cognitive-neurophysiological 
measures in the male-only sample
  Anxiety symptoms  Group x Anxiety symptoms
 (95% CI) p  (95% CI) p
Memory
DSB  0.01 [-0.15;0.16] 0.95  0.01 [-0.25;0.28] 0.92
Fast Task
MRT-baseline  -0.14 [-0.27;-0.01] 0.04  0.24 [-0.01;0.49] 0.06
RTV-baseline  -0.19 [-0.35;-0.04] 0.02  0.28 [-0.01;0.58] 0.06
SCL-baseline  -0.07 [-0.21;0.08] 0.37  0.08 [-0.19;0.36] 0.56
CPT-OX
OE  0.06 [-0.24;0.37] 0.68  -0.21 [-0.67;0.25] 0.37
CE  -0.11 [-0.42;0.20] 0.49  0.59 [0.10;1.07] 0.02
CNV  -0.05 [-0.19;0.08] 0.44  0.08 [-0.19;0.34] 0.57
NoGo-P3  0.08 [-0.07;0.23] 0.31  0.05 [-0.26;0.37] 0.74
Arrow Flanker Task
CongE  0.13 [-1.20;1.5] 0.85  0.42 [-0.02;0.85] 0.06
IncongE  0.10 [-0.04;0.24] 0.16  0.28 [-0.01;0.57] 0.06
ERN  0.01 [-0.15;0.17] 0.91  -0.33 [-0.65;-0.01] 0.05
Results from the final regression model examining associations of anxiety symptoms with the cognitive-
neurophysiological measures, as well as the group and the anxiety x group interaction effects, controlling for 
age in males only. ADHD, attention-deficit/hyperactivity disorder; CI: confidence intervals; CongE, errors in the 
congruent condition of the arrow Flanker task; CNV, contingent negative variation from the cued-continuous 
performance test measured at Cz; CPT-OX, cued-continuous performance test; DSB, digit span backward; ERN, 
error-related negativity amplitude from the arrow Flanker task measured at FCz; IncongE, errors in the 
incongruent condition of the arrow Flanker task; MRT-baseline, mean reaction time from the baseline condition 
of the Fast task; NoGo-P3, P3 amplitude in the NoGo condition from the cued-continuous performance test 
measured at Cz; OE, omission errors from the cued-continuous performance test; CE, commission errors from 
the cued-continuous performance test; RTV-baseline, reaction time variability from the baseline condition of 
the Fast task; SCL-baseline, skin conductance level in the baseline condition of the Fast Task. 
Figure 1. Predicted mean anxiety symptoms in individuals with attention-deficit/hyperactivity disorder 
(ADHD) and controls. The means are based on estimated anxiety symptoms for each group corrected for 
age. The error bars represent standard errors. 
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Figure 2. Predicted mean commission errors on the cued-continuous performance test as a function of 
anxiety symptoms in individuals with attention-deficit/hyperactivity disorder (ADHD) and controls. The 
means are based on estimated commission errors for each group at each level of anxiety symptoms 
corrected for age. 
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Supplementary material 1: Task details, event related potential (ERP) and skin conductance (SC) 
extraction.
The Cued-Continuous Performance test (CPT-OX) 
For the CPT-OX task, stimuli are presented for 150 ms with a stimulus onset asynchrony of 1.65 s in a 
pseudorandomized order at the center of a computer monitor. Trials are presented in one block. Task 
duration is approximately 11 min. Stimulus-locked epochs (stimulus window from  to 1650ms) 
were averaged based on three different response conditions: Cue, Go and NoGo. Averages were 
calculated for trials with correct responses (Go) or correctly rejected trials (NoGo and Cue), which 
included at least 20 artefact-free segments. Based on previous research (Albrecht et al., 2013; 
Doehnert, Brandeis, Schneider, Drechsler, & Steinhausen, 2013; McLoughlin et al., 2010), ERP 
measures were identified within selected electrodes and latency windows for which effects were 
expected to be largest. These measures were then confirmed separately for each group using 
topographic maps (Cheung et al., 2017). In Cue trials, the P3 was measured at Pz between 300-650ms, 
and the CNV was measured at Cz between 1300-1650ms. In Go trials, the P3 was measured at CPz and 
Pz between 250-500ms. No clear N2 was observed in Go trials, consistent with other studies 
employing tasks with low conflict-monitoring demands (Gajewski & Falkenstein, 2013; Michelini et al., 
2016) and was, therefore, not included in the analysis. In NoGo trials, the P3 was measured at FCz and 
Cz between 250-550ms and the N2 was measured at Fz between 175-325ms. The CNV was analysed 
as mean amplitudes between 1300 and 1650ms following cues over the central electrode (Cz). The 
cue-P3 had a parietal maximum and was defined as the most positive peak between 250 and 600 ms 
following cue trials at electrode Pz. The nogo-P3 was defined as the most positive peak between 250 
and 600 ms following No-Go trials at electrode Cz. 
The arrow Flanker task 
In the arrow Flanker task, when the target appears, both target and flankers remain on the screen for 
a further 150 ms, with a new trial being presented every 1.65 s. Trials were arranged in 10 blocks of 
40 trials. Task duration is approximately 13 min. Analyses of ERPs of performance monitoring from 
this task were restricted to the incongruent condition, as the task used in this study is known to elicit 
strong N2, error related negativity (ERN) and positivity (Pe) components in high-conflict, but not in 
low-conflict, conditions (Albrecht et al., 2008; McLoughlin et al., 2009). Baseline correction was 
applied using the -300 to -100 ms pre-target (-200 to 0 ms pre-flanker) interval, following the protocol 
of previous ERP analyses on the arrow flanker task (Michelini et al., 2016). Data were segmented based 
on (1) stimulus-locked incongruent trials where a correct response was made and (2) response-locked 
(error-related) incongruent trials where an incorrect response was made. Individual averages were 
created based on each condition, requiring  20 clean segments for each participant. After averaging, 
the electrodes and latency windows for ERP analyses were selected based on previous studies 
(Albrecht et al., 2008; Groom et al., 2010; McLoughlin et al., 2009; Michelini et al., 2016) topographic 
maps and the grand averages. The N2 was measured as maximum negative peak at Fz and FCz 
between 250-450 ms after target onset. The ERN was defined with respect to the preceding positivity 
(PNe, -100-50 ms) in order to obtain a more robust measure of this component (23-25), and was 
measured at FCz between 0-150 ms. The Pe was measured as maximum positive peak at CPz between 
150-450 ms after an erroneous response on incongruent trials.    
The Fast Task 
In the Fast Task, stimuli are presented for 8000 ms and for 1000 ms in the baseline and fast-
incentive conditions, respectively, after which one of them (the target) was coloured in 
(Andreou et al., 2007; Kuntsi, Andreou, Ma, Borger, & van der Meere, 2005). Following a 
response, the stimuli disappeared from the screen and a fixed inter-trial interval of 2.5s 
followed. P3 amplitude was analysed as the area amplitude measure  at Pz between 
250 and 450ms, to reduce bias due to the varying noise levels induced by the different task 
conditions (Luck, 2005). For the P3 analyses, all the accepted trials were baseline-corrected 
using a pre-stimulus baseline of 200ms. The mean amplitudes of this pre-target period (-
200ms - 0ms, using a technical zero baseline as in previous CNV work 46,47) at Cz were also 
analysed separately as a CNV measure. This short interval not only corresponded to the P3 
baseline, but also captured the short CNV in the fast-incentive condition with its one-second 
cue – target interval (Cheung et al., 2017; James, Cheung, Rijsdijk, Asherson, & Kuntsi, 2016).
Skin conductance (SC)
SC data values were calculated using a skin conductance system which is based on a SC 
sigmoid-exponential model that allows the tonic measure of SC level (SCL) to be disentangled 
from phasic, stimulus-associated, SC responses (SCR), and further allows the decomposition 
of overlapping SCRs. This system, therefore, is appropriate to use in conditions with long and 
short inter-stimulus-intervals. The statistical model was applied to each condition, as a whole. 
SCR amplitude (change in SC from the baseline to the highest point of the SCR) was derived 
from this method, and was calculated on a trial-by-trial basis. The criteria for the smallest SCR 
were set at 0.02 µS. Means of SC variables (SCL) were calculated per participant, across each 
condition (James et al., 2016).  
Supplementary Figure 1: Distribution of anxiety symptoms in individuals with attention-
deficit/hyperactivity disorder (ADHD) and controls.
Supplementary Table S1. Results of regression model analyses showing main effects of group, 
anxiety and the interaction between anxiety and group on the cognitive-neurophysiological 
measures controlling for IQ
  Anxiety symptoms  Group x Anxiety symptoms
 (95% CI) P  (95% CI) p
Memory
DSB  -0.08 [-0.18;0.02] 0.14  0.08 [-0.11;0.27] 0.42
Fast Task
MRT-baseline  -0.02 [-0.14;0.11] 0.80  0.14 [-0.08;0.35] 0.21
RTV-baseline  -0.06 [-0.20;0.08] 0.37  0.17 [-0.07;0.42] 0.17
SCL-baseline  -0.08 [-0.19;0.05] 0.20  0.02 [-0.22;0.26] 0.85
CPT-OX
OE  0.01 [-0.18;0.20] 0.89  -0.02 [-0.34;0.32] 0.93
CE  -0.18 [-0.40;0.04] 0.11  0.54 [0.19;0.89] 0.003
CNV  -0.01 [-0.10;0.08] 0.80  0.01 [-0.18;0.20] 0.95
NoGo-P3  0.00 [-0.11;0.11] 0.99  0.15 [-0.08;0.38] 0.21
Arrow Flanker Task
CongE  0.34 [-0.52;1.19] 0.44  0.08 [-0.19;0.36] 0.57
IncongE  0.05 [-0.05;0.16] 0.31  0.16 [-0.07;0.40] 0.18
ERN  -0.04 [-0.18;0.10] 0.61  -0.18 [-0.44;0.08] 0.18
Results from the regression model examining associations of binary ADHD diagnosis (ADHD vs. control) and 
anxiety symptoms scores with the cognitive-neurophysiological measures, as well as the anxiety x diagnosis 
interaction effects, controlling for IQ. ADHD, attention-deficit/hyperactivity disorder; CI: confidence intervals; 
CongE, errors in the congruent condition of the arrow flanker task; CNV, contingent negative variation from the 
cued-continuous performance test measured at Cz; CPT-OX, cued-continuous performance test; DSB, digit span 
backward; ERN, error-related negativity amplitude from the arrow flanker task measured at FCz; IncongE, errors 
in the incongruent condition of the arrow flanker task; MRT-baseline, mean reaction time from the baseline 
condition of the Fast task; NoGo-P3, P3 amplitude in the NoGo condition from the cued-continuous performance 
test measured at Cz; OE, omission errors from the cued-continuous performance test; CE, commission errors 
from the cued-continuous performance test; RTV-baseline, reaction time variability from the baseline condition 
of the Fast task; SCL-baseline = skin conductance level in the baseline condition of the Fast Task; *p<0.05; 
**p<0.01; ***p<0.001. Boldface indicates P value remains significant following multiple testing (effective 
number-adjusted P value threshold of 0.0048).         
Supplementary Table S2. Results of regression model analyses showing main effects of group, 
combined anxiety (anxiety + obsessive-compulsive) symptoms, and the interaction between 
combined anxiety and group on the cognitive-neurophysiological measures
  Anxiety symptoms  Group x Anxiety symptoms
 (95% CI) P  (95% CI) p
Memory
DSB  -0.08 [-0.20;0.49] 0.23  -0.01 [-0.24;0.22] 0.90
Fast Task
MRT-baseline  0.03 [-0.09;0.16] 0.58  0.13 [-0.10;0.37] 0.26
RTV-baseline  -0.02 [-0.14;0.10] 0.76  0.17 [-0.06;0.41] 0.14
SCL-baseline  -0.12 [-0.25;0.02] 0.09  0.04 [-0.24;0.31] 0.79
CPT-OX
OE  0.1 [-0.12;0.33] 0.36  -0.08 [-0.40;0.24] 0.62
CE  <0.01 [-0.19;0.19] 0.98  0.33 [0.02;0.64] 0.03
CNV  0.03 [-0.05;0.11] 0.48  -0.04 [-0.23;0.15] 0.67
NoGo-P3  -0.06 [-0.18;0.06] 0.33  0.16 [-0.08;0.41] 0.19
Arrow Flanker Task
CongE  0.47 [-0.44;1.38] 0.31  0.25 [-0.05;0.54] 0.10
IncongE  0.12 [0.02;0.22] 0.02  0.15 [-0.06;0.36] 0.16
ERN  -0.07 [-0.19;0.06] 0.28  -0.11 [-0.35;0.13] 0.35
Results from the regression model examining associations of binary ADHD diagnosis (ADHD vs. control) and 
combined anxiety-OCD symptoms scores with the cognitive-neurophysiological measures, as well as the anxiety-
OCD x diagnosis interaction effects. ADHD, attention-deficit/hyperactivity disorder; CI: confidence intervals; 
CongE, errors in the congruent condition of the arrow flanker task; CNV, contingent negative variation from the 
cued-continuous performance test measured at Cz; CPT-OX, cued-continuous performance test; DSB, digit span 
backward; ERN, error-related negativity amplitude from the arrow flanker task measured at FCz; IncongE, errors 
in the incongruent condition of the arrow flanker task; MRT-baseline, mean reaction time from the baseline 
condition of the Fast task; NoGo-P3, P3 amplitude in the NoGo condition from the cued-continuous performance 
test measured at Cz; OE, omission errors from the cued-continuous performance test; CE, commission errors 
from the cued-continuous performance test; RTV-baseline, reaction time variability from the baseline condition 
of the Fast task; SCL-baseline = skin conductance level in the baseline condition of the Fast Task. No P values 
remain significant following multiple testing (effective number-adjusted P value threshold of 0.0048).         
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